Motivation: Spectral count data generated from label-free tandem mass spectrometry-based proteomic experiments can be used to quantify protein's abundances reliably. Comparing spectral count data from different sample groups such as control and disease is an essential step in statistical analysis for the determination of altered protein level and biomarker discovery. The Fisher's exact test, the G-test, the t-test and the local-pooled-error technique (LPE) are commonly used for differential analysis of spectral count data. However, our initial experiments in two cancer studies show that the current methods are unable to declare at 95% confidence level a number of protein markers that have been judged to be differential on the basis of the biology of the disease and the spectral count numbers. A shortcoming of these tests is that they do not take into account within-and between-sample variations together. Hence, our aim is to improve upon existing techniques by incorporating both the within-and between-sample variations. Result: We propose to use the beta-binomial distribution to test the significance of differential protein abundances expressed in spectral counts in label-free mass spectrometry-based proteomics. The beta-binomial test naturally normalizes for total sample count. Experimental results show that the beta-binomial test performs favorably in comparison with other methods on several datasets in terms of both true detection rate and false positive rate. In addition, it can be applied for experiments with one or more replicates, and for multiple condition comparisons. Finally, we have implemented a software package for parameter estimation of two beta-binomial models and the associated statistical tests. Availability and implementation: A software package implemented in R is freely available for download at
INTRODUCTION
Mass spectrometry-based proteomics is an important technique for large-scale identification and quantification of proteins. It has been shown that the number of spectral counts of a protein can be used as a measure of its abundance (Dix et al., 2008; Liu et al. , * To whom correspondence should be addressed. 2004; Ramani et al., 2008; Zybailov et al., 2009) . In comparison to intensity-based quantification which requires complex signal processing, quantification using spectral counts is advantageous because the numbers are readily available after protein identification. However, tools for statistical analysis of this type of data are still immature. This article addresses the problem of comparative analysis of spectral count data generated in label-free tandem mass spectrometry-based proteomics.
We make a distinction between within-and between-sample variation. The former refers to variation caused by the random sampling process of each biological sample. The latter is the variation resulted from random biological samples in a sample group such as control or disease.
Since the number of samples per comparison group is typically small (currently, n varies from 1 to 6 for data generated in our laboratory), non-parametric methods such as the Mann-Whitney test or the Kruskal-Wallis test are usually not powerful. One often resorts to assumptions about the generative mechanism of the data in the form of parametric distributions. In particular, the popular t-test assuming a normal distribution can be used with either the raw spectral count numbers or their transformed values (e.g. logarithm or square root transformation). The t-test, however, does not take into account within-sample variation. Figure 1 shows a mean-variance plot of proteins resulted from a single biological sample after 29 LC/MS/MS runs (see Section 3.1 for a detailed description). It can be seen that the absolute variance tends to increase for proteins at higher abundance. Thus, ignoring the within-sample variation may result in artificially large test statistics for proteins at a high abundance region.
When there is only one replicate available in each sample group, the G-test of independence or the Fisher's exact test can be used by forming a 2×2 contingency table for each protein (Sokal and Rohlf, 1995) . The two tests are based on the assumption of a multinomial distribution and a hypergeometric distribution of the number of counts, respectively. Hence, effectively the within-sample variation is modeled. However, when more than one replicates are available, the current non-optimal approach is to pool the samples, and as a result ignoring the between-sample variability.
This article proposes to use the beta-binomial distribution (Skellam, 1948) to model spectral count data. The variability is modeled in two directions. The within-sample variation is modeled with a binomial distribution, similar to the assumption employed in the G-test of independence or the Fisher's exact test. The between-sample variation is modeled by treating the parameter of the binomial distribution as a random variable from a beta distribution. Finally, parameter inference is based on the likelihood ratio test as in the case of the G-test.
The article is organized as follows. Section 2 presents the beta-binomial test. Section 3 evaluates the performance of the betabinomial test and existing tests for spectral count data. Section 4 concludes the article.
THE BETA-BINOMIAL MODEL
Let x ∈ N denote the number of spectral counts of a particular protein and n ∈ N the total number of spectral counts of all proteins in a sample. To model the within-sample variation, assume x is distributed according a binomial distribution with success probability π ∈ R, 0≤ π ≤ 1,
Furthermore, for the between-sample variation, π is modeled as a random variable from a beta distribution with real parameters α>0 and β>0
where B(·,·) is the beta function. The marginal distribution of x is then the beta-binomial distribution (Skellam, 1948) 
The maximum likelihood estimation of the parameters α and β of the beta-binomial distribution is as follows. Ignoring constants involving only the data, the log likelihood
being the number of data points, is
where i and r are running indices, µ = α(α+β) −1 and θ = (α+β) −1 (Williams, 1975) . The reparameterization is to improve the numerical stability of the optimization algorithm. In addition, µ is the expected value of the binomial parameter π. The likelihood ratio test can be used for significance analysis (Sokal and Rohlf, 1995) . Let L j be the maximal value of the log likelihood (4) for each group, j = 1,...,M. Let L 0 be the maximal value of the log likelihood when data from all groups are used. In the first model, the statistic S to test the homogeneity across groups
is approximately χ 2 distributed with 2(M −1) degrees of freedom. Here, the null hypothesis is equal to µ j and θ j . (Hence, there are 2M free parameters in one model and two free parameters in the other model, which leads to 2(M −1) degrees of freedom for the χ 2 distribution.) When the beta distributions are bell shaped (θ j <µ j , θ j < 1−µ j ), the groups may differ with respect to µ but not with respect to θ (Williams, 1975) . In this case, we can use the second model where the θ j are constrained to be equal. Here, we test the hypothesis that µ j are equal assuming that θ j are equal. The distribution of the statistic S in (5) under the null hypothesis is approximated by the χ 2 distribution with (M −1) degrees of freedom. (This is because there are (M +1) free parameters in one model and two free parameters in the other model, resulting in (M −1) degrees of freedom for the χ 2 distribution.)
There are two special cases in implementing the beta-binomial test for spectral count data.
• µ j = 0: this situation arises either from the random sampling process or from a black and white regulation of the protein. In this case, µ j = 0 maximizes (4) and L j = 0. We do not address the issue with asymptotic approximations as stated in Crowder (1978) and simply omit the contribution of group j in (5).
• θ j = 0: the situation arises when there is one replicate only or when the between-sample variation diminishes. This indicates that the data might be pooled. In fact, in this case the unique solution for µ j is equal to the binomial parameter π + of the pooled data.
Note that instead of using the likelihood ratio test, the betabinomial distribution can be used for testing in other frameworks (Baggerly et al., 2003; Ennis and Bi, 1998) . Nevertheless, the main computational task is still the optimization of (4).
EXPERIMENTAL RESULTS
We contrast the performance of the beta-binomial test against existing statistical tests. Two important criteria for comparison are the true detection rate and false positive rate.
Previous comparative studies (Bantscheff et al., 2007; Zhang et al., 2006) indicate that for experiments with a single replicate in each group the G-test, the Fisher's exact test and the so-called AC test perform equally well. The G-test is favorable because of its computational simplicity and its applicability for comparison with multiple conditions. Thus, we will consider the G-test as a representative for the class of methods dealing with one replicate.
In Bantscheff et al. (2007) , the t-test is recommended for experiments with more than three replicates, while the local-poolederror technique (LPE) test is suited for ones with two or three replicates. Hence, in this sample size setting we contrast the performance of the beta-binomial test against the G-test, the t-test and the LPE test. Moreover, we also attempt to use the t-test with log-transformed data (after normalization for total sample count), a procedure often carried out as a preprocessing step for genomic data.
The QSpec method is a recent development in differential analysis of spectral count data (Choi et al., 2008) . It is a Bayesian modeling technique where the spectral counts are modeled as observations from a Poisson distribution, which is similar to the binomial assumption. However, statistical information across proteins is also employed in QSpec as opposed to the beta-binomial model where each protein is treated separately. We will use an implementation of QSpec provided by its authors in our evaluation. For protein marker discovery, a threshold of 9.8 on the Bayes factor is used as in Choi et al. (2008) .
We also perform evaluation for three group comparisons. In addition to the G-test, one-way ANOVA and one-way ANOVA with log-transformation are considered.
On the existence of within-sample variation and extra-binomial total variation
The first dataset is spectral count data from 29 LC/MS/MS runs of colon cancer cell line HTC116, which were used >6 months as technical control samples to evaluate equipment performance. The MS/MS spectra were identified by SEQUEST. The identified peptides were organized by the Scaffold 2 software (Proteome Software Inc., Portland, OR, USA; see Supplementary Material I). The resulted dataset contains 656 proteins in total (min 2 peptides/protein, 99% protein probability). There is no biological variation in the set. We used this dataset to illustrate the existence of within-sample variation (Fig. 1 ). We performed a test for the null hypothesis that the binomial proportions over 29 samples in this dataset are the same (using prop.test in R). The spectral count numbers are normalized for the total sample spectral count. This is important because of the differences in sample load (the number of total spectral counts for each sample ranges from 936 to 2868). The result shows that only 27 out of 656 proteins (4%) show heterogeneity of binomial proportions at 95% confidence level. Figure 2a shows a protein with a high degree of homogeneousity among the proportions. In this case, the beta-binomial fit coincides with a binomial fit (θ = 0).
Next, we analyzed a dataset with two cancer groups, one with three biological samples and the other with five biological samples. In total the dataset contains 1786 proteins. In each sample, there are approximately 20 000 spectral counts. The proportion test shows that 965 out of 1786 proteins (54%) indicate heterogeneity of binomial proportions at 95% confidence level in either group. Therefore, modeling data with a binomial distribution, or equivalently pooling the data, is clearly not sufficient. Figure 2b illustrates an example of one protein with extrabinomial variation. It can be seen that the binomial model is inadequate here as two out of five points lie at the extreme tails of the estimated binomial distribution. Thus, pooling the data in this case will create a false estimate of the variance. The extra-binomial variation can be well modeled by a beta-binomial distribution.
On true detection rate
We use two real-life datasets from two cancer proteomics studies conducted in our laboratory to examine the ability of the betabinomial test to detect differential proteins. Both studies require a two-group comparison. The first dataset is a comparative analysis of colon adenomas and carcinomas. Human cancer tissues were prepared to extract, among others, the so-called chromatin-binding fraction (Albrethsen et al., 2009) . Subsequently, the chromatinbinding fractions are subjected to a processing pipeline including gel electrophoresis, in-gel digestion, nano-LC separation, tandem mass spectrometry and database searching (Supplementary Material I). The second dataset was generated for the comparative analysis of proximal fluids obtained from normal colon and colon tumor samples of a mouse model. The samples were again subjected to the aforementioned gel-LC-MS/MS proteomics workflow to obtain spectral count data (Supplementary Material I) .
Evaluating the true detection rate is difficult because in general there is no ground truth available on differential proteins. One approach is to generate a synthetic list of differential proteins. However, it is not certain that the generative mechanism will be close to that of real-life data. We therefore employed an approximate method. For each dataset, we used a list of potentially differential proteins provided by experts as an (approximate) ground truth. Both differential protein lists had been composed prior to the implementation of the test. Candidate proteins came from literature. Some were established clinical and preclinical protein markers for the cancer. Some had been found to be differential in other medium or compartments rather than the ones under study here. Typically, these candidate proteins are used for confirmatory analysis. For colorectal cancer, the proteins are CEA, CEACAM-6, TIMP-1, MMP-9, PKM2 and LF.
While it is not certain that all proteins in the lists will express significant difference in the datasets, it should give an indication on the relative performance of the different statistical tests. Furthermore, within each protein list there is a sub-list of proteins which are known markers for the cancer. Thus, in comparison to the full list, the proteins in the sub-list are more likely to be differential.
In the first study, a list of 58 potential protein markers was composed. This list contains six proteins which are known markers for the cancer. Similarly, there is a list of 50 potential protein markers in the second study, of which 11 are known markers. Figure 3 compares the detection rate of the beta-binomial test against the G-test, the t-test, the LPE test and QSpec. It can be seen that the beta-binomial test detects the most differential proteins at the 95% confidence level in three cases. In particular, only the beta-binomial test can declare all existing markers significantly differential. While QSpec can detect 24 out of 58 candidate proteins for dataset 1, it detects only four out of six protein markers for the dataset. The t-test with log-transformation and QSpec perform as well as the beta-binomial test for the second dataset. Thus, one can conclude that the beta-binomial test outperforms the G-test, the t-test and the LPE test in terms of detection rate. It is comparable with the t-test when the data are log transformed and the QSpec method.
As an aside, it is interesting to observe the difference in true detection rate for the two datasets. Recall that the first dataset comes from a comparison between two stages of cancer, whereas the second dataset comes from a cancer versus control comparison. It can be expected that the differences in protein abundance are more apparent for the cancer versus control comparison. Here the result shows that the beta-binomial test, the t-test with log transformation and QSpec have 100% detection rate for the second dataset and <50% detection rate for the first dataset. Some of the proteins not detected in the first dataset might be false expert assignments. Some might be . 3 . The number of true detections of six methods on two datasets with four (approximate) ground truth lists: the beta binomial test, the G test, the t-test, the t-test with log-transformation, the LPE method, and QSpec. The beta binomial test, the t-test with log-transformation, and QSpec perform comparably, and outperform other methods.
differential in other compartments but not in the chromatin-binding fraction. For the purpose of this article, it is important to note that the lists of candidate proteins were independently identified from the development of the tests.
On false positive rate

Two-group comparison
We followed the work of Zhang et al. (2006) for a comprehensive comparison of statistical tests for differential analysis of spectral count data. The dataset for evaluation comes from the work of Liu et al. (2004) . The spectral count data is obtained from Saccharomyces cerevisiae cell lysate samples with six additional protein markers added at three different concentrations (2.5, 1.25 and 0.25%). The six protein markers are bovine carbonic anhydrase (CAH2), bovine serum albumin (ALBU), soybean trypsin inhibitor (ITRA), chicken lysozyme (LYC), chicken ovalbumin (OVAL) and rabbit phosphorylase b (PHS2). In Zhang et al. (2006) , the authors focused on the false positive rate of two-group comparison. For each spiked-in protein, the false positive rate is the fraction of the number of proteins with lower P-value than the P-value of the designated protein. This evaluation metric is sensible especially for biomarker discovery applications because the investigator may vary the threshold for marker selection.
We repeat the experiment in Zhang et al. (2006) with the G-test, the t-test and the LPE test. For the G-test, if more than one replicates are available, the data are pooled. The result is adjusted by the William's correction method (see Sokal and Rohlf, 1995; Zhang et al., 2006 , for detail of the correction). For the t-test and LPE test, the data are normalized for total sample count. As in the evaluation for true detection rate, we also report the result of the t-test on log-transformed data (after total sample count normalization).
The QSpec method requires proteins' sequence length. This information can be obtained from http://www.yeastgenome.org/, and is available in Supplementary Material III.
Three pairwise comparisons among three different spiked-in concentrations were performed (2.5% versus 1.25%, 1.25% versus 0.25% and 2.5% versus 0.25%), resulting in comparisons with 2-, 5-and 10-fold changes, respectively. The effect of the number of replicates is evaluated by considering each comparison with one, two and three replicates. For one and two replicates, the false positives rates are averaged from all nine possible combinations (this is because there are three replicates available in each group). The one-replicate comparison is not applicable for the t-test and the LPE test. The beta-binomial test can be used for all cases. Figure 4 reports the false positive rates of different tests in different settings of fold change and sample size. We were able to reproduce the result of Zhang et al. (2006) , except for the comparison 1.25% versus 2.5% with two replicates, where our result of LPE test (∼10%) is lower than the result in Zhang et al. (2006) (∼18%) . This might be due to the different parameter setting of the LPE algorithm and/or software version. It can be seen that the t-test with log-transformation exhibits similar behavior as the t-test without data transformation. Both versions are worse than other methods for the 5-and 10-fold changes.
For one-replicate experiment, the beta-binomial test performs as well as the G-test, and as QSpec in most cases. [Note that the standard deviations (SDs) are approximately equal to the means. Only in the 5-fold comparison, the performance of QSpec appears considerably worse than that of the other two tests.] For two-and three-replicate experiments, the beta-binomial test outperforms all others. The false negative rate of the beta-binomial test is higher than that of the t-test in one case only (for protein CAH2, 2-fold change). The result of the beta-binomial test is equal and in many cases significantly better than that of other tests.
The results across different fold changes and different numbers of replicates are expected in that it is more difficult to detect 2-fold differences than 5-and 10-fold differences. In addition, increasing the number of replicates reduces the false positive rate. Another observation is that the six proteins result in different false positive rates. This is because the proteins are based on different subsets of peptides whose chemical and physical properties are different, for instance, the ionization property and the number of tryptic peptides. This leads to differences in detectablity and variation.
Three-group comparison
We contrast the beta-binomial test against the G-test (for multiple groups) (Sokal and Rohlf, 1995) , one-way ANOVA and one-way ANOVA with log-transformation. Note that the LPE test is not applicable in this case. For one and two replicates, the false positives rates are averaged from all 27 possible combinations (again, this is because there are three replicates available in each group). For experiments with more than one replicates, data are pooled for the G-test. Only the beta-binomial test and G-test are applicable for one-replicate experiments. Figure 5 shows the performance of the different tests with one and two replicates. When all three replicates are used, no false positive is reported for all the tests. It can be seen that the beta-binomial test performs as well as the G-test for one-replicate experiment and outperforms all other tests for the two-replicate situation.
DISCUSSIONS
We proposed to use the beta-binomial distribution to model spectral count data with both within-and between-sample variation in labelfree tandem mass spectrometry-based proteomics. The experimental results showed that the beta-binomial test compares favorably with other existing tests in significance analysis of spectral count data in terms of true detection rate and false positive rate.
For datasets with a single replicate in each group, the betabinomial test and the G-test perform comparably. This is expected since the extra-binomial variation in the beta-binomial model diminishes, resulting in a binomial model. On the other hand, under the constraint of equal sample load, the multinomial distribution assumed by the G-test turns into a binomial distribution for the two-group comparison. Nevertheless, the use of the beta-binomial test is advantageous in a situation where a sample group has more than one replicates, while another group has only a single replicate. Our experiment showed that data should not be pooled at convenience when more than one replicates are available.
The true detection rates of the beta-binomial test, the t-test with log-transformation and QSpec are similar and considerably better than the t-test without data transformation and the LPE method. This is likely because the first three tests model the spectral count data on the non-negative side, whereas the other two tests cannot impose this restriction, which has a clear impact especially when the counts concentrate near zero.
A recent study (Chourey et al., 2009) used the Poisson regression model for spectral count data. Our analysis shows that in case of twogroup comparison, the model leads to pooling data in each group in the log space. Hence, it belongs to the class of methods where the G-test is representative. Nevertheless, the Poisson regression model is flexible and can be taken into account in other settings such as for paired data, time-course data and experimental designs with multi-way interactions.
The beta-binomial distribution has been used for analysis of differential gene expression level in SAGE libraries in Baggerly et al. (2003) , in which model fitting is based on the method of moments. It is unclear if this approach can be generalized to handle constraints on parameters for different likelihood ratio tests, for example, to consider the difference between group means only. Beta binomial test test One-way ANOVA One-way ANOVA with log-transformation Our implementation uses an optimization procedure where the result of the method of moments is used as an initial estimate, and extension for parameter constraints is straightforward. An alternative mathematical model for two directions of variation is the gamma-Poisson distribution. Here, the within-sample variation is modeled with a Poisson distribution, and the other with a gamma distribution. Our experiment with within-sample variation indicates a strong similarity between the binomial model and the Poisson model. Further evaluation is necessary to judge the performance of the gamma-Poisson model.
In terms of computational speed, the beta-binomial test is slower than the G-test, the t-test, the LPE test and one-way ANOVA. Its speed is roughly equal to that of QSpec with the default setting. Nevertheless, the computational time is marginal in comparison with other processing steps such as sample preparation and mass spectrometry. Furthermore, the processing of multiple proteins is easily parallelizable. Thus, this issue is negligible.
Finally, we have implemented a robust software package in R for hypothesis testing with the beta-binomial model for spectral count data. An option for correction for multiple testing is included in the package.
